{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:58:59Z","timestamp":1789473539799,"version":"build-2803163510"},"reference-count":33,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>The global prevalence of arterial hypertension (AH) in the pediatric population is increasing, but therapeutic approaches and the choice of the most suitable antihypertensive medications remains challenging. The study aimed to estimate the prevalence, treatment rates, and pharmacological treatment patterns of children and adolescents with AH in Lithuania during 2019 using real-world data. The study population consisted of citizens of Lithuania aged 0 to 17 years, who were diagnosed with AH according to the International Classification of Diseases (ICD). The analysis of reimbursed antihypertensive medication prescriptions was performed according to AH etiology and age. The overall prevalence of AH by diagnostic ICD codes in 2019 was 0.29%:0.24% for primary and 0.05% for secondary. Treatment rates were 39.8% for primary AH and 66.3% for secondary AH. Angiotensin-converting enzyme inhibitors (ACEi) were the most popular medications irrespective of the etiology of AH or age. Beta-blockers were in the second place and used more often in older children. Calcium channel blockers were the third and angiotensin receptor blockers were the fourth most frequent choices. Enalapril was the most popular agent in the ACEi group and metoprolol in the beta-blocker group. Nearly forty percent of Lithuanian children with primary AH receive pharmacological therapy compared to two-thirds with secondary AH. Although ACEi are the predominant class of antihypertensive medications, discordances with available guidelines are evident, particularly in the overuse of beta-blockers and underuse of diuretics.<\/jats:p>","DOI":"10.3390\/ijerph192113949","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T04:35:17Z","timestamp":1666845317000},"page":"13949","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Pharmacological Treatment of Arterial Hypertension in Children and Adolescents in Lithuania"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4073-7985","authenticated-orcid":false,"given":"Eleonora","family":"Ivanova","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Vilnius University, 03101 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0013-0564","authenticated-orcid":false,"given":"Dovil\u0117","family":"Ruzgien\u0117","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Vilnius University, 03101 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolis","family":"A\u017eukaitis","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Vilnius University, 03101 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7767-2102","authenticated-orcid":false,"given":"Augustina","family":"Jankauskien\u0117","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Vilnius University, 03101 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1097\/HJH.0000000000001039","article-title":"2016 European Society of Hypertension Guidelines for the Management of High Blood Pressure in Children and Adolescents","volume":"34","author":"Lurbe","year":"2016","journal-title":"J. Hypertens."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0895-7061(95)00116-7","article-title":"Essential Hypertension Predicted by Tracking of Elevated Blood Pressure from Childhood to Adulthood: The Bogalusa Heart Study","volume":"8","author":"Bao","year":"1995","journal-title":"Am. J. Hypertens."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1093\/oxfordjournals.aje.a116217","article-title":"Serial Changes in Blood Pressure from Adolescence into Adulthood","volume":"135","author":"Beckett","year":"1992","journal-title":"Am. J. Epidemiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJMoa0904130","article-title":"Childhood Obesity, Other Cardiovascular Risk Factors, and Premature Death","volume":"362","author":"Franks","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"d643","DOI":"10.1136\/bmj.d643","article-title":"Association of Blood Pressure in Late Adolescence with Subsequent Mortality: Cohort Study of Swedish Male Conscripts","volume":"342","author":"Neovius","year":"2011","journal-title":"BMJ"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1161\/HYPERTENSIONAHA.119.14168","article-title":"Elevated Blood Pressure in Childhood or Adolescence and Cardiovascular Outcomes in Adulthood: A Systematic Review","volume":"75","author":"Yang","year":"2020","journal-title":"Hypertension"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1007\/s00467-010-1626-7","article-title":"Regression of Target Organ Damage in Children and Adolescents with Primary Hypertension","volume":"25","author":"Litwin","year":"2010","journal-title":"Pediatr. Nephrol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/jamapediatrics.2019.3310","article-title":"Global Prevalence of Hypertension in Children: A Systematic Review and Meta-Analysis","volume":"173","author":"Song","year":"2019","journal-title":"JAMA Pediatr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1097\/HJH.0b013e3282ef48b2","article-title":"Prevalence of Hypertension in Schoolchildren Based on Repeated Measurements and Association with Overweight","volume":"25","author":"Chiolero","year":"2007","journal-title":"J. Hypertens."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/08037051.2010.542649","article-title":"An Approach of Hypertension Prevalence in a Sample of 5381 Portuguese Children and Adolescents. The AVELEIRA Registry. \u201cHypertension in Children\"","volume":"20","author":"Maldonado","year":"2011","journal-title":"Blood Press."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.amjcard.2015.02.063","article-title":"APV initiative and the BMBF Competence Network Obesity Blood Pressure in 57,915 Pediatric Patients Who Are Overweight or Obese Based on Five Reference Systems","volume":"115","author":"Neuhauser","year":"2015","journal-title":"Am. J. Cardiol."},{"key":"ref_12","unstructured":"Gadzijeva, U., and Zidoniene, I. (2020). Vaiku Sveikata, Higienos Institutas."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/jama.298.8.874","article-title":"Underdiagnosis of Hypertension in Children and Adolescents","volume":"298","author":"Hansen","year":"2007","journal-title":"JAMA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jpeds.2015.04.016","article-title":"Hypertension Prevalence, Cardiac Complications, and Antihypertensive Medication Use in Children","volume":"167","author":"Dobson","year":"2015","journal-title":"J. Pediatr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.ekir.2022.02.018","article-title":"High Blood Pressure in Children and Adolescents: Current Perspectives and Strategies to Improve Future Kidney and Cardiovascular Health","volume":"7","author":"Robinson","year":"2022","journal-title":"Kidney Int. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Bouhanick, B., Sosner, P., Brochard, K., Mounier-V\u00e9hier, C., Plu-Bureau, G., Hascoet, S., Ranchin, B., Pietrement, C., Martinerie, L., and Boivin, J.M. (2021). Hypertension in Children and Adolescents: A Position Statement From a Panel of Multidisciplinary Experts Coordinated by the French Society of Hypertension. Front. Pediatr., 9.","DOI":"10.3389\/fped.2021.680803"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"(2004). National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. Pediatrics, 114, 555\u2013576.","DOI":"10.1542\/peds.114.2.S2.555"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0140-6736(21)01688-3","article-title":"Global and National High Blood Pressure Burden and Control","volume":"398","author":"Nguyen","year":"2021","journal-title":"Lancet"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/HJH.0000000000000447","article-title":"Effects of Blood Pressure Lowering on Outcome Incidence in Hypertension: 4. Effects of Various Classes of Antihypertensive Drugs\u2014Overview and Meta-Analyses","volume":"33","author":"Thomopoulos","year":"2015","journal-title":"J. Hypertens."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Flynn, J.T., Kaelber, D.C., Baker-Smith, C.M., Blowey, D., Carroll, A.E., Daniels, S.R., de Ferranti, S.D., Dionne, J.M., Falkner, B., and Flinn, S.K. (2017). Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics, 140.","DOI":"10.1542\/peds.2017-1904"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4330\/wjc.v6.i5.234","article-title":"Anti-Hypertensive Drugs in Children and Adolescents","volume":"6","author":"Chu","year":"2014","journal-title":"World J. Cardiol."},{"key":"ref_22","first-page":"498","article-title":"Pharmacological Interventions for Hypertension in Children","volume":"9","author":"Chaturvedi","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00467-013-2510-z","article-title":"Rational Use of Antihypertensive Medications in Children","volume":"29","author":"Ferguson","year":"2014","journal-title":"Pediatr. Nephrol. Berl. Ger."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fped.2018.00148","article-title":"Cardiac and Vascular Target Organ Damage in Pediatric Hypertension","volume":"6","author":"Khoury","year":"2018","journal-title":"Front. Pediatr."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00467-020-04731-z","article-title":"Evolution of Isolated Systolic Hypertension with Normal Central Blood Pressure in Adolescents\u2014Prospective Study","volume":"36","author":"Obrycki","year":"2021","journal-title":"Pediatr. Nephrol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Kaelber, D.C., Liu, W., Ross, M., Localio, A.R., Leon, J.B., Pace, W.D., Wasserman, R.C., Fiks, A.G., and for the Comparative Effectiveness Research Through Collaborative Electronic Reporting (CER2) Consortium (2016). Diagnosis and Medication Treatment of Pediatric Hypertension: A Retrospective Cohort Study. Pediatrics, 138.","DOI":"10.1542\/peds.2016-2195"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jadohealth.2013.12.006","article-title":"Use of Antihypertensive Medications and Diagnostic Tests among Privately Insured Adolescents and Young Adults with Primary versus Secondary Hypertension","volume":"55","author":"Yoon","year":"2014","journal-title":"J. Adolesc. Health Off. Publ. Soc. Adolesc. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.medici.2017.07.004","article-title":"Utilization of Cardiovascular Medicines and Cardiovascular Mortality in Lithuania, Sweden and Norway in 2003\u20132012","volume":"53","year":"2017","journal-title":"Medicina"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.amjhyper.2004.09.009","article-title":"A Double-Blind, Dose-Response Study of Losartan in Hypertensive Children","volume":"18","author":"Shahinfar","year":"2005","journal-title":"Am. J. Hypertens."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1177\/009127002401102786","article-title":"Enalapril Pediatric Hypertension Collaborative Study Group A Double-Blind, Placebo-Controlled, Dose-Response Study of the Effectiveness and Safety of Enalapril for Children with Hypertension","volume":"42","author":"Wells","year":"2002","journal-title":"J. Clin. Pharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s11906-012-0302-7","article-title":"What Is the Optimal First-Line Agent in Children Requiring Antihypertensive Medication?","volume":"14","author":"Batisky","year":"2012","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_32","first-page":"1101","article-title":"[Lacidipine efficacy and safety for high blood pressure treatment in pediatric oncohematology]","volume":"21","author":"Bernard","year":"2014","journal-title":"Arch. Pediatr. Organe Off. Soc. Francaise Pediatr."},{"key":"ref_33","first-page":"440","article-title":"Features of antihypertensive therapy and real-world prescription of selective imidazoline receptor agonists in Russia vs other countries: STRAIGHT study data analysis","volume":"93","author":"Konradi","year":"2021","journal-title":"Ter. Arkh."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/21\/13949\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:03:47Z","timestamp":1760144627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/21\/13949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,27]]},"references-count":33,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["ijerph192113949"],"URL":"https:\/\/doi.org\/10.3390\/ijerph192113949","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,27]]}}}